Genocea surges as co's data makes it to top 10 featured abstracts of cancer journal

Genocea Biosciences

31/05/2019 16:45

** Shares of drug developer  GNCA.O  surge as much as ~78%
to $8
    ** Co says an American Society of Clinical Oncology (ASCO)
Journal selected co's clinical results presentation for its
vaccine candidate GEN-009 as a top 10 featured abstract in
immuno-oncology  urn:newsml:reuters.com:*:nGNX54MYl6
    ** GNCA says GEN-009 is being tested across a variety of
solid tumor types
    ** More than 4.1 mln shares change hands, ~73x the co's
50-day moving average
    ** Up to Thursday's close, GNCA had nearly doubled this year

 (Reporting by Manojna Maddipatla)
 ((Reuters Messaging:
manojna.kalyani.thomsonreuters.com@reuters.net))